Department of Radiology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.
Department of Radiology, Banan People's Hospital, Chongqing Medical University, Chongqing, 401320, China.
Acad Radiol. 2023 Jul;30(7):1247-1256. doi: 10.1016/j.acra.2022.10.014. Epub 2022 Nov 15.
To prospectively investigate the potential correlation between qualitative and quantitative assessment of aneurysm wall enhancement (AWE) on initial enhanced high-resolution magnetic resonance imaging (HR-MRI) and aneurysm progression during follow-up.
From June 2016 to January 2021, we prospectively recruited patients with unruptured intracranial aneurysms (UIAs) for enhanced HR-MRI examination. The patients' demographic and clinical data and aneurysm characteristics, including AWE features, were collected and analyzed. Follow-up images were compared to evaluate IA progression. Univariate and multivariate Cox proportional hazards regression analyses were performed to identify the risk factors associated with aneurysm progression.
Seventy-seven patients with 95 UIAs met our research criteria, and the median follow-up time was 15.7 months. Progression was observed in 18 aneurysms; the remaining 77 remained stable. Progressive UIAs were larger in size, more frequently displayed obvious AWE and showed a higher enhancement ratio (ER) than nonprogressive UIAs. Multivariate Cox regression analysis showed that both ER (hazard ratio, 6.304, p < 0.001) and aneurysm size (hazard ratio, 1.343, p = 0.014) were independent risk factors for aneurysm progression. The combination of ER and aneurysm size had an area under the curve of 0.920 for the prediction of aneurysm progression, with a sensitivity of 88.9% and specificity of 87.0%.
A higher ER value of the aneurysm wall and a larger aneurysm size on initial HR-MRI may predict an increased risk of aneurysm progression, which suggests that closer monitoring by imaging or preventive intervention may be required for the clinical management of these aneurysms.
前瞻性研究初始增强高分辨率磁共振成像(HR-MRI)上动脉瘤壁增强(AWE)的定性和定量评估与随访期间动脉瘤进展之间的潜在相关性。
从 2016 年 6 月至 2021 年 1 月,我们前瞻性地招募了未破裂颅内动脉瘤(UIAs)患者进行增强 HR-MRI 检查。收集并分析了患者的人口统计学和临床数据以及动脉瘤特征,包括 AWE 特征。比较随访图像以评估 IA 进展。进行单变量和多变量 Cox 比例风险回归分析,以确定与动脉瘤进展相关的危险因素。
77 例 95 个 UIAs 符合我们的研究标准,中位随访时间为 15.7 个月。18 个动脉瘤出现进展;其余 77 个保持稳定。进展性 UIAs 较大,更常显示明显的 AWE,增强率(ER)更高。多变量 Cox 回归分析显示,ER(危险比,6.304,p < 0.001)和动脉瘤大小(危险比,1.343,p = 0.014)均是动脉瘤进展的独立危险因素。ER 和动脉瘤大小的组合对预测动脉瘤进展的曲线下面积为 0.920,具有 88.9%的敏感性和 87.0%的特异性。
初始 HR-MRI 上动脉瘤壁的更高 ER 值和更大的动脉瘤大小可能预示着动脉瘤进展的风险增加,这表明对于这些动脉瘤的临床管理可能需要通过影像学进行更密切的监测或预防性干预。